Back

S1P as a novel target to address adverse outcomes following acute myocardial infarction

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Residual risk in ischaemic heart disease: thrombotic and vascular mechanisms Thrombosis, Platelets, and Coagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Evanthia Pavlidou

University of Zurich, Schlieren (Switzerland)

5 More presentations in this session

Presentation thumbnail
Platelet dysfunction, liver fibrosis and adverse outcomes in individuals with ischemic heart disease: a post-hoc analysis of the prospective observational EVA study
Doctor G. Guadalupi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Effects of icosapent ethyl on coagulation biomarkers and their association with event‑free survival in high‑risk cardiovascular patients: a post hoc analysis of the REDUCE-IT
Ms A. Kuenzli (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Infection drives excessive platelet inhibition during P2Y12 inhibitor therapy in coronary artery disease
Doctor L. Weiss (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Hypertension-associated acetate deficiency enhances platelet activation and thrombosis via Olfr78
Doctor Y. Chen (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
A dense fibrin network favours layered plaque formation in the infarct-related artery in patients with ST-segment elevation myocardial infarction
Doctor K. Karwat (Krakow, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Residual risk in ischaemic heart disease: thrombotic and vascular mechanisms

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction
25 August 2023
thumbnail
Congress Presentation
Biomarker profiles for the assessment of cardiac remodeling
19 May 2025
thumbnail
Congress Presentation
HFWM: impact of Sphingosine Kinase 1 and S1P signaling in post-ischemic cardiomyocytes
13 May 2024
thumbnail
Congress Presentation
Targeted modulation of sphingolipid signaling to inhibit the progression of aortic valve disease
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources